ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.3250
+0.0100 (3.17%)
Sep 25, 2026, 4:10 PM AEST
ImExHS Market Cap
ImExHS has a market cap or net worth of 17.68 million as of September 25, 2026. Its market cap has increased by 36.62% in one year.
Market Cap
17.68M
Enterprise Value
16.15M
Revenue
31.27M
Ranking
n/a
PE Ratio
93.88
Stock Price
0.33
ChartMarket Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 17.68M, a decrease of -29.27%. That is a compound annual growth rate of -4.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 17.68M | -18.23% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 521.83M |
| Monash IVF Group | 292.23M |
| Healius | 261.42M |
| Cryosite | 57.60M |
| Microba Life Sciences | 35.02M |
| BCAL Diagnostics | 31.34M |
| Rhythm Biosciences | 29.02M |
| INOVIQ | 25.34M |